Contract Research
GSK, US HHS team up to develop drugs against antibiotic resistance and bioterrorism
By
GlaxoSmithKline (GSK) has teamed up with Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and Human Services (HHS), to develop drugs against antibiotic resistance and bioterrorism.
Contract Research & Services > Contract Research > News
GlaxoSmithKline (GSK) has teamed up with Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and Human Services (HHS), to develop drugs against antibiotic resistance and bioterrorism.
Contract Research & Services > Contract Research > News
DBV, Stallergenes sign strategic research partnership targeting respiratory allergies
By
DBV Technologies and Stallergenes have signed a strategic research partnership for the development of new treatment of respiratory allergies.
Contract Research & Services > Contract Research > News RuiYi, Genor sign RYI-008 development deal in China By
RuiYi and Genor BioPharma have signed an exclusive license and collaborative development agreement for RYI-008 in China.
Contract Research & Services > Contract Research > News
DBV Technologies and Stallergenes have signed a strategic research partnership for the development of new treatment of respiratory allergies.
Contract Research & Services > Contract Research > News RuiYi, Genor sign RYI-008 development deal in China By
RuiYi and Genor BioPharma have signed an exclusive license and collaborative development agreement for RYI-008 in China.
Contract Research & Services > Contract Research > News
Latest Contract Research News and Insight
View all Contract Research news or find news targeted to your interests
AbbVie, Alvine to jointly develop new therapy for celiac disease
AbbVie and Alvine Pharmaceuticals have collaborated to develop investigational oral therapy ALV003 for celiac disease.
Contract Research & Services > Contract Research > News
Contract Research & Services > Contract Research > News
COPA-DATA establishes new branch office in Ludwigshafen am Rhein
COPA-DATA Germany GmbH continues to promote long-term and sustainable growth and establishes a new branch office in Ludwigshafen am Rhein. The goal is to provide even better support and service to existing local customers as well as gain new customers in the Rheinland-Pfalz area. Furthermore, COPA-DATA has founded the "Competence Center Business Intelligence" at the new location, in order to meet the increasing demand for information analysis and evaluation solutions.
Contract Research & Services > Contract Research > Press Releases
Contract Research & Services > Contract Research > Press Releases
Amgen, Zhejiang Beta partner to commercialize Vectibix in China
Amgen and Zhejiang Beta Pharma have signed an agreement to form a joint venture (JV) to commercialize Amgen's Vectibix (panitumumab) in the Chinese market.
Contract Research & Services > Contract Research > News
Contract Research & Services > Contract Research > News
BioTrinity 2013 - European Biopartnering and Investment Conference - May 14-16, 2013
BioTrinity is the premier European Biopartnering and Investment Conference, partnering R&D companies with big pharma and more biomedical investors than any other European partnering conference. Check out who else is coming, we expect about 850 delegates including nearly 80 investment firms, hear what delegates say about BioTrinity, the expert discussion panels, and which 90 companies will be presenting in the showcase.
Contract Research & Services > Contract Research > Press Releases
Contract Research & Services > Contract Research > Press Releases
Isis Pharmaceuticals earns $3.5m in milestone payment from Biogen Idec
Isis Pharmaceuticals has earned $3.5m in milestone payment from Massachusetts-based drugmaker Biogen Idec related with the dosing of the first patient in the second phase study of ISIS-SMNRx in infants with spinal muscular atrophy (SMA).
Contract Research & Services > Contract Research > News
Contract Research & Services > Contract Research > News
Theravance, Elan enter into royalty participation agreement
Us-based companies Theravance and Elan have entered into a $1.0bn royalty participation agreement.
Contract Research & Services > Contract Research > News
Contract Research & Services > Contract Research > News
Adaptive signs biomarker discovery partnership in oncology with Bristol-Myers
Adaptive Biotechnologies has signed immunological biomarker discovery partnership with Bristol-Myers Squibb in the field of oncology.
Contract Research & Services > Contract Research > News
Contract Research & Services > Contract Research > News
Astellas, Drais partner to develop nocturia compound through Tacurion
Astellas Pharma and Drais Pharmaceuticals have partnered to develop and commercialize third Astellas compound, being developed to treat nocturia through Tacurion Pharma.
Contract Research & Services > Contract Research > News
Contract Research & Services > Contract Research > News
Concert Pharmaceuticals, Celgene to develop deuterium-modified compounds
Concert Pharmaceuticals and Celgene Corporation have entered into strategic collaboration to direct deuterium-modified compounds targeting cancer and inflammation.
Contract Research & Services > Contract Research > News
Contract Research & Services > Contract Research > News
MorphoSys reaches milestone in ophthalmology program with Novartis
MorphoSys has reached a milestone in ophthalmology program for the development of HuCAL-derived, fully human antibody, with Novartis.
Contract Research & Services > Contract Research > News
View all Contract Research news or find news targeted to your interests
Contract Research & Services > Contract Research > News
Buy the latest industry research online today!
African Pharmaceutical Directory 2013
API research into pharmaceutical companies and corporations
Buy online from $200